Sommer R, Wagner S, Rox K, Varrot A, Hauck D, Wamhoff E, Schreiber J, Ryckmans T, Brunner T, Rademacher C, Hartmann R, Brönstrup M, Imberty A, Titz A.
Glycomimetic, Orally Bioavailable LecB Inhibitors Block Biofilm Formation of Pseudomonas aeruginosa. Journal of the American Chemical Society 2018

Sommer R, Wagner S, Rox K, Varrot A, Hauck D, Wamhoff E, Schreiber J, Ryckmans T, Brunner T, Rademacher C, Hartmann R, Brönstrup M, Imberty A, Titz A.
Glycomimetic, Orally Bioavailable LecB Inhibitors Block Biofilm Formation of Pseudomonas aeruginosa. Journal of the American Chemical Society 2018

Sommer, R., Wagner, S., Varrot, A., Hauk, D., Ryckmans, T., Hartman, R.W., Brunner, T., Rademacher, C., Imberty, A., Titz, A.
To be published. Discovery of a new class of C-glycoside based inhibitors of the virulence factor LecB from Pseudomonas aeruginosa. To be published. 2017

Sommer R, Wagner S, Varrot A, Nycholat C, Khaledi A, Häussler S, Paulson J, Imberty A, Titz A.
The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery. Chemical science 2016

Sommer R, Wagner S, Varrot A, Nycholat C, Khaledi A, Häussler S, Paulson J, Imberty A, Titz A.
The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery. Chemical science 2016

Sommer R, Wagner S, Varrot A, Nycholat C, Khaledi A, Häussler S, Paulson J, Imberty A, Titz A.
The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery. Chemical science 2016

Sommer R, Wagner S, Varrot A, Nycholat C, Khaledi A, Häussler S, Paulson J, Imberty A, Titz A.
The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery. Chemical science 2016